Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Integrative dual ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumor transcription and resistance phenotypes in metastatic prostate cancer.
Journal: Research square
Published: February 12, 2026
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: March 27, 2025
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.
Journal: Research square
Published: December 16, 2024
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.
Journal: The Journal of clinical investigation
Published: December 04, 2024
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.
Journal: medRxiv : the preprint server for health sciences
Published: November 28, 2024
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.
Journal: Nature communications
Published: November 22, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.
Journal: Cancer research
Published: June 20, 2024
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Journal: The Prostate
Published: July 04, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Journal: Nature communications
Published: September 30, 2020
Last Updated: 09/26/2026